-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind Medicine issues press release update

PUBT·07/07/2026 11:42:24
Listen to the news
Clearmind Medicine issues press release update
  • Clearmind published a press release on July 7, 2026, reporting a successful formulation feasibility study for intranasal delivery of MEAI.
  • Results showed MEAI was incorporated into the formulation as a stable, fully soluble solution, supporting further development of the intranasal program.
  • The intranasal route is being evaluated as an additional administration option, initially targeting alcohol use disorder.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607070742PRIMZONEFULLFEED9758107) on July 07, 2026, and is solely responsible for the information contained therein.